Track topics on Twitter Track topics that are important to you
The MiniMed Mio Advance, which builds on the MinMed Mio insulin infusion set intended for insulin delivery from an insulin pu -More-
To replace an existing insulin vial filling line and expand insulin production
Insulin pump therapy was associated with lower rates of severe hypoglycemia and ketoacidosis and better glycemic control compared with insulin injection therapy in a pediatric population.
Sanofi’s rapid-action insulin, Admelog, will be the first “follow-on” insulin product on the market to help diabetics manage their blood sugar at mealtimes. Sanofi has announced the...
Admelog is a rapid-acting insulin similar to Humalog, another insulin lispro 100 Units/mL, currently approved in the U.S.
Voluntis has received FDA clearance and CE mark to integrate Basaglar and Tresiba insulins into its insulin titrating mobile app, Insulia, making the app available to any brand of basal insulin, accor...
December 11, 2017 -- The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pe...
December 11, 2017 -- The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a rapid-acting insulin indicated to improve control in blood sugar levels in adults and pe...
Insulin resistance could increase insulin requirements in type 1 diabetes (TD1). Current insulin immunoassays do not detect insulin analogues. Kinase Insulin Receptor Activation (KIRA) bioassays speci...
Insulin allergy is a rare yet severe side effect of exogenous insulin use. Management typically involves use of alternative antihyperglycaemic agents, symptom control with antihistamines, use of diffe...
Insulin signalling deficiencies and insulin resistance have been directly linked to the progression of neurodegenerative disorders like Alzheimer's disease. However, to date little is known about the ...
We compared the efficacy of insulin detemir and biphasic insulin aspart-30 given in the morning as an add-on to oral hypoglycemic agents (OHAs) in type 2 diabetic patients.
We report two cases of hypoglycaemia; one with apparently spontaneous hypoglycaemia and one with presumed insulin overdose. In both cases insulin concentration was normal when measured with the Roche ...